Literature DB >> 29770882

Does obesity influence the results in Transvaginal Hybrid-NOTES cholecystectomy?

Dirk R Bulian1, Jurgen Knuth2,3, Panagiotis Thomaidis2, Anna Rieger2, Claudia Simone Seefeldt2, Jonas Lange2, Jurgen Meyer2, Michael A Stroehlein2, Markus M Heiss2.   

Abstract

BACKGROUND: Morbidly obese patients are usually excluded from studies that compare Transvaginal Hybrid-NOTES Cholecystectomy (TVC) with traditional laparoscopic cholecystectomy. Therefore, these study results cannot necessarily be transferred to this group of patients. In this study, we have analyzed and compared the outcomes of the procedure with obese and non-obese patients.
METHODS: Data from a prospectively maintained database were retrospectively analyzed. All the TVCs performed in our clinic since 2008 were divided into groups according to their body mass index (BMI). Within these groups, we evaluated the following outcome parameters: age, ASA classification, procedural time, number of percutaneous trocars, intra- and postoperative complications, and postoperative hospital stay. Additionally, the posthospital surgical and gynecological follow-up was evaluated for additional complications and patients with class III obesity were contacted to determine further parameters.
RESULTS: Six underweight, 76 normal weight, 72 overweight, 48 class I obesity, 15 class II obesity, and 20 class III obesity patients were analyzed. ASA classification (P < 0.001), procedural time (P < 0.001), and number of percutaneous trocars (P < 0.001) significantly increased with the BMI. By contrast, intra- and postoperative complications (P = 0.134 and P = 0.571), as well as postoperative hospital stay (P = 0.076) did not depend on the BMI. Neither did the classification according to Clavien/Dindo show a significant relation (P = 0.640). Lethality was zero. All posthospital gynecological follow-ups were inconspicuous. Telephone follow-up of class III obesity patients reached a rate of 85% after median 3.4 years. There were no additional complications or problems during sexual intercourse. The satisfaction with the cosmetic and the overall result was very high.
CONCLUSIONS: Although the results of existing studies including normal-weight or merely moderately obese patients can hardly be applied to morbidly obese patients, especially regarding procedural time and the number of percutaneous trocars, obesity should not be an exclusion criterion for TVC, regardless of its magnitude.

Entities:  

Keywords:  Body mass index; Complications; NOTES; Obesity; Transvaginal cholecystectomy

Mesh:

Year:  2018        PMID: 29770882     DOI: 10.1007/s00464-018-6216-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  22 in total

1.  Transvaginal laparoscopically assisted endoscopic cholecystectomy: preliminary clinical results for a series of 43 cases in China.

Authors:  Jun Niu; Wei Song; Ming Yan; Wei Fan; Weibo Niu; Enyu Liu; Cheng Peng; Pengfei Lin; Peng Li; Abdul Qadir Khan
Journal:  Surg Endosc       Date:  2010-10-07       Impact factor: 4.584

2.  Less pain after transvaginal/transumbilical cholecystectomy than after the classical laparoscopic technique: short-term results of a matched-cohort study.

Authors:  Dirk Rolf Bulian; Linda Trump; Jürgen Knuth; Robert Siegel; Axel Sauerwald; Michael A Ströhlein; Markus Maria Heiss
Journal:  Surg Endosc       Date:  2012-08-28       Impact factor: 4.584

3.  [Comparison between transvaginal and laparoscopic cholecystectomy - a retrospective case-control study].

Authors:  M Hensel; U Schernikau; A Schmidt; G Arlt
Journal:  Zentralbl Chir       Date:  2010-05-05       Impact factor: 0.942

4.  Comparison of outcome and side effects between conventional and transvaginal laparoscopic cholecystectomy: a meta-analysis.

Authors:  Jian Xu; Liang Xu; Lintao Li; Siluo Zha; Zhiqian Hu
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2014-10       Impact factor: 1.719

Review 5.  Determinants for gallstone formation - a new data cohort study and a systematic review with meta-analysis.

Authors:  Daniel Mønsted Shabanzadeh; Lars Tue Sørensen; Torben Jørgensen
Journal:  Scand J Gastroenterol       Date:  2016-05-27       Impact factor: 2.423

6.  Comparison of short-term outcomes between transvaginal hybrid NOTES cholecystectomy and laparoscopic cholecystectomy.

Authors:  Byron F Santos; Ezra N Teitelbaum; Fahd O Arafat; Magdy P Milad; Nathaniel J Soper; Eric S Hungness
Journal:  Surg Endosc       Date:  2012-05-02       Impact factor: 4.584

7.  Transvaginal-hybrid vs. single-port-access vs. 'conventional' laparoscopic cholecystectomy: a prospective observational study.

Authors:  Maik Kilian; Wieland Raue; Charalambos Menenakos; Brit Wassersleben; Jens Hartmann
Journal:  Langenbecks Arch Surg       Date:  2011-03-08       Impact factor: 3.445

8.  Postoperative pain after transvaginal cholecystectomy: single-center, double-blind, randomized controlled trial.

Authors:  Dietmar H Borchert; Matthias Federlein; Frauke Fritze-Büttner; Jens Burghardt; Britta Liersch-Löhn; Yüksel Atas; Verena Müller; Oskar Rückbeil; Stefan Wagenpfeil; Stefan Gräber; Klaus Gellert
Journal:  Surg Endosc       Date:  2014-01-24       Impact factor: 4.584

9.  Transvaginal/transumbilical hybrid--NOTES--versus 3-trocar needlescopic cholecystectomy: short-term results of a randomized clinical trial.

Authors:  Dirk Rolf Bulian; Jürgen Knuth; Nicola Cerasani; Axel Sauerwald; Rolf Lefering; Markus Maria Heiss
Journal:  Ann Surg       Date:  2015-03       Impact factor: 12.969

10.  Risk factors for requiring cholecystectomy for gallstone disease in a prospective population-based cohort study.

Authors:  A Talseth; E Ness-Jensen; T-H Edna; K Hveem
Journal:  Br J Surg       Date:  2016-05-25       Impact factor: 6.939

View more
  1 in total

1.  Comparative analysis of postoperative pain after transvaginal hybrid NOTES versus traditional laparoscopic cholecystectomy in obese patients.

Authors:  Dirk R Bulian; Sebastian Walper; Dana C Richards; Sissy-A Schulz; Claudia S Seefeldt; Panagiotis Thomaidis; Jurgen Meyer-Zillekens; Markus M Heiss
Journal:  Surg Endosc       Date:  2021-11-03       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.